nalmefene has been researched along with Chronic Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernhard, JD; Luger, TA; Phan, NQ; Ständer, S | 1 |
| Manara, AR; Merriman, RJ; Mills, IH; Park, GR | 1 |
| Monroe, EW | 1 |
1 review(s) available for nalmefene and Chronic Disease
| Article | Year |
|---|---|
Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
Topics: Administration, Oral; Antipruritics; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Naloxone; Naltrexone; Pruritus; Randomized Controlled Trials as Topic; Receptors, Opioid, mu; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2010 |
2 trial(s) available for nalmefene and Chronic Disease
| Article | Year |
|---|---|
Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions.
Topics: Adult; Anesthetics, Dissociative; Anorexia; Chronic Disease; Compulsive Personality Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Ketamine; Memory; Naltrexone; Narcotic Antagonists; Treatment Outcome | 1998 |
Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis.
Topics: Chronic Disease; Dermatitis, Atopic; Double-Blind Method; Humans; Naltrexone; Narcotic Antagonists; Placebos; Pruritus; Random Allocation; Urticaria | 1989 |